Judy C. Boughey, MD, on What Can Be Learned From I-SPY2 Analysis About Changes in Axillary Surgical Management

Posted: Friday, May 12, 2023

Judy C. Boughey, MD, of the Mayo Clinic, discusses the clinical implications of findings showing that the use of axillary lymph node dissection has declined in the past decade, especially among patients with node-positive breast cancer at diagnosis who had sentinel lymph node surgery after neoadjuvant chemotherapy.